Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   PCE(x) 22.4916.66--

What is the latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of PIRAMAL PHARMA is 22.49 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202422.49
Mar202316.66
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of PIRAMAL PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 22.49
34.99
Mar2023 16.66
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹30,544.1 Cr -1.1% -6.1% 62.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,699.0 Cr 0.6% -4.6% 20.7% Stock Analytics
DIVIS LABORATORIES ₹162,584.0 Cr 9.8% 4.5% 64.7% Stock Analytics
CIPLA ₹116,022.0 Cr -2.9% -3.9% 1.1% Stock Analytics
DR REDDYS LABORATORIES ₹102,463.0 Cr 0.9% -10.4% 0.1% Stock Analytics
ZYDUS LIFESCIENCES ₹98,434.8 Cr 0.9% -0.3% 27.9% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-1.1%

-6.1%

62.9%

SENSEX

2%

0.1%

8.6%


You may also like the below Video Courses